Stay updated on Pembrolizumab in HER2+ Gastric Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in HER2+ Gastric Clinical Trial page.

Latest updates to the Pembrolizumab in HER2+ Gastric Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe changes consist of adding Revision: v3.3.2 and removing Revision: v3.3.1, which are minor version updates that do not alter core page content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check16 days agoChange DetectedAdded notes explaining that publications are provided voluntarily by study personnel and may be auto-filled from PubMed. Updated the revision to v3.3.1 and removed older wording about PubMed-derived listings.SummaryDifference0.2%

- Check23 days agoChange DetectedThe government funding status banner was removed from the page. The rest of the trial details remain unchanged, including the study overview, eligibility criteria, and locations.SummaryDifference0.1%

- Check38 days agoChange DetectedThe observed changes are limited to metadata such as the page's last update date and results posting information, with no modification to core trial content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check66 days agoChange DetectedAdded a government-operating-status notice and updated version to v3.2.0; removed the old version tag v3.0.2.SummaryDifference1%

- Check68 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0 with no substantive content changes.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab in HER2+ Gastric Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in HER2+ Gastric Clinical Trial page.